Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$507,114,486
+$313,784,802 QoQ
Shares Held
2,015,238
+126.7% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#81
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $6,352,612,055 across 16 Drug Manufacturers - General names. ABBV ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
27,357,486 | $1,576,338,337 | |
| 2 | LLY |
ELI LILLY & Co
|
1,035,605 | $1,242,135,802 | |
| 3 | MRK |
Merck & Co., Inc.
|
8,134,262 | $1,045,252,665 | |
| 4 | JNJ |
Johnson & Johnson
|
2,907,803 | $738,494,723 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
2,015,238 | $507,114,486 | |
| 6 | PFE |
Pfizer Inc
|
18,557,891 | $446,874,011 | |
| 7 | BIIB |
Biogen Inc.
|
1,936,859 | $418,477,751 | |
| 8 | AMGN |
Amgen Inc
|
300,007 | $108,638,532 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $507,114,486 | 2,015,238 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $193,329,684 | 888,913 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $262,933,950 | 1,150,746 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $214,600,993 | 926,842 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $110,999,273 | 597,992 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $162,190,687 | 774,106 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $257,374,813 | 1,448,367 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $338,033,229 | 1,711,734 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $240,887,489 | 1,404,428 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $280,157,754 | 1,538,483 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $285,934,680 | 1,845,097 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $223,155,638 | 1,497,086 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $157,017,574 | 1,165,424 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $190,323,478 | 1,194,224 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $229,778,229 | 1,421,807 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $195,671,201 | 1,457,948 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $255,217,858 | 1,666,348 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $291,464,053 | 1,797,940 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $274,900,995 | 2,030,288 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $212,768,828 | 1,972,456 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $210,504,785 | 1,868,828 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $244,184,036 | 2,256,367 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $263,768,797 | 2,461,678 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $321,638,975 | 3,672,097 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $522,874,378 | 5,325,671 | Shares | Other | 2020-08-17 | |
| 2020-03-31 | $230,786,289 | 3,029,089 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||